ClinicalTrials.Veeva

Menu

Development of "T-sec" Questionnaire

F

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Status

Enrolling

Conditions

Asthma

Treatments

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT05546645
IIBSP-TSC-2022-09

Details and patient eligibility

About

To design and validate a questionnaire that allows objective assessment of the level of bronchial mucus hypersecretion.

Full description

Asthma is a chronic inflammatory disease associated with bronchial mucus hypersecretion (MBH) due to various mechanisms, such as increased mucin secretion, plasma exudation and cytokines. It is currently known that MBH in asthmatic patients is associated with increased mortality and reduced pulmonary function, but there is no tool for its objective assessment.

The aim of the study is to design and validate a questionnaire to objectively assess the level of bronchial mucus hypersecretion in patients with asthma.

Enrollment

100 estimated patients

Sex

All

Ages

30 to 99 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Aged between 30 and 99 years
  • Clinical diagnosis of asthma

Exclusion criteria

  • Non-Spanish-speaking patients
  • Inability to complete the questionnaires
  • Failure to sign the informed consent form.

Trial contacts and locations

1

Loading...

Central trial contact

Esther Palones, MD; Astrid Crespo-Lessmann, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems